F
Frank Hanses
Researcher at University Hospital Regensburg
Publications - 113
Citations - 2252
Frank Hanses is an academic researcher from University Hospital Regensburg. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 81 publications receiving 1395 citations. Previous affiliations of Frank Hanses include Brigham and Women's Hospital & University of Regensburg.
Papers
More filters
Journal ArticleDOI
Epidemiology of SARS-CoV-2
Bernd Salzberger,F Buder,Benedikt M J Lampl,Boris Ehrenstein,Florian Hitzenbichler,Thomas Holzmann,Barbara Schmidt,Frank Hanses +7 more
TL;DR: Despite a rapid worldwide spread, attack rates have been low in most regions, demonstrating the efficacy of control measures.
Journal ArticleDOI
Influenza pandemic and professional duty: family or patients first? A survey of hospital employees
TL;DR: It is suggested that a modest majority of HCP, but only a minority of hospital administrators, recognises the obligation to treat patients despite the potential risks and professional ethical guidelines allowing for balancing the needs of society with personal risks are needed to help HCP fulfil their duties in the case of a pandemic influenza.
Journal ArticleDOI
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Jon Salmanton-García,Rosanne Sprute,Jannik Stemler,Michele Bartoletti,Damien Dupont,Damien Dupont,Maricela Valerio,Carolina Garcia-Vidal,Iker Falces-Romero,Marina Machado,Sofía de la Villa,Maria Schroeder,I. Hoyo,Frank Hanses,Kennio Ferreira-Paim,Daniele Roberto Giacobbe,Jacques F. Meis,Jean-Pierre Gangneux,Azucena Rodríguez-Guardado,Spinello Antinori,Ertan Sal,Xhorxha Malaj,Danila Seidel,Oliver A. Cornely,Philipp Koehler +24 more
TL;DR: Wang et al. as mentioned in this paper collected data from 186 patients who had coronavirus disease-associated pulmonary aspergillosis (CAPA) worldwide during March-August 2020, and found that the cumulative incidence of CAPA in the ICU ranged from 1.0% to 39.1%.
Journal ArticleDOI
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
David Peterhoff,Vivian Glück,Matthias Vogel,Philipp Schuster,Anja Schütz,P Neubert,Veruschka Albert,Stefanie Frisch,Mara Kiessling,Philip Pervan,Maren Werner,Nicole Ritter,Leon Babl,Maria Deichner,Frank Hanses,Matthias Lubnow,Thomas Müller,Dirk Lunz,Florian Hitzenbichler,Franz Audebert,Viola Hähnel,Robert Offner,Martina Müller,S Schmid,Ralph Burkhardt,Thomas Glück,Michael Koller,Hans Helmut Niller,Bernhard M. Graf,Bernd Salzberger,Jürgen J. Wenzel,Jonathan Jantsch,Jonathan Jantsch,André Gessner,André Gessner,Barbara Schmidt,Barbara Schmidt,Ralf Wagner,Ralf Wagner +38 more
TL;DR: Due to high specificity and strong correlation with virus neutralization, the RBD ELISA holds great potential to become a preferred tool to assess thresholds of protective immunity after infection and vaccination.
Journal ArticleDOI
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry
Maria Rüthrich,C. Giessen-Jung,Stefan Borgmann,Annika Y. Classen,Sebastian Dolff,Beate Grüner,Frank Hanses,Nora Isberner,Philipp Köhler,Julia Lanznaster,Uta Merle,Silvio Nadalin,Christiane Piepel,J. Schneider,J. Schneider,M. Schons,R. Strauss,Lukas Tometten,Jorg-Janne Vehreschild,Jorg-Janne Vehreschild,M. von Lilienfeld-Toal,Gernot Beutel,Kai Wille +22 more
TL;DR: In this paper, the authors present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk.